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Abstract
Clethramycin from Streptomyces malaysiensis DSM4137, and mediomycins (produced together with clethramycin from Strepto-
myces mediocidicus), are near-identical giant linear polyenes apparently constructed from, respectively, a 4-guanidinobutanoate or
4-aminobutanoate starter unit and 27 polyketide extender units, and bearing a specific O-sulfonate modification at the C-29 hydroxy
group. We show here that mediomycins are actually biosynthesised not by use of a different starter unit but by direct late-stage
deamidination of (desulfo)clethramycin. A gene (slf) encoding a candidate sulfotransferase has been located in both gene clusters.
Deletion of this gene in DSM4137 led to accumulation of desulfoclethramycin only, instead of a mixture of desulfoclethramycin
and clethramycin. The mediomycin gene cluster does not encode an amidinohydrolase, but when three candidate amidinohydrolase
genes from elsewhere in the S. mediocidicus genome were individually expressed in Escherichia coli and assayed, only one of them
(medi4948), located 670 kbp away from the mediomycin gene cluster on the chromosome, catalysed the removal of the amidino
group from desulfoclethramycin. Subsequent cloning of medi4948 into DSM4137 caused mediomycins A and B to accumulate at
the expense of clethramycin and desulfoclethramycin, respectively, a rare case where an essential biosynthetic gene is not co-locat-
ed with other pathway genes. Clearly, both desulfoclethramycin and clethramycin are substrates for this amidinohydrolase. Also,
purified recombinant sulfotransferase from DSM4137, in the presence of 3'-phosphoadenosine-5'-phosphosulfate as donor, effi-
ciently converted mediomycin B to mediomycin A in vitro. Thus, in the final steps of mediomycin A biosynthesis deamidination
and sulfotransfer can take place in either order.
Introduction
Bacterial modular polyketide synthases (PKSs) follow an
assembly-line paradigm for enzyme catalysis, in which each
round of chain extension requires a different set, or module, of
enzymatic activities [1-4]. Among the more remarkable natural
products derived by this pathway is the giant linear polyene
clethramycin (1a, Scheme 1), originally isolated as an anti-
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Scheme 1: The structures of clethramycin, mediomycins and related linear polyenes.
fungal and as an inhibitor of pollen tube outgrowth from a
plant-associated Streptomyces hygroscopicus strain [5].
Clethramycin (together with desulfoclethramycin (1b)) is also a
product of the prolific strain Streptomyces malaysiensis
DSM4137 (formerly Streptomyces violaceusniger DSM4137)
[6] and it co-occurs with the closely-related antifungal
mediomycins A (1c) and B (1d, Scheme 1) in Streptomyces
mediocidicus ATCC 23936 [7]. Mediomycins are also pro-
duced by Streptomyces blastmyceticus [8]. The genes for the
assembly-line PKS for mediomycin from S. blastmyceticus have
been recently reported, encoding a separate extension module
for all 27 cycles of chain extension [8]. These systems are
attractive targets for knowledge-based engineering to produce
novel antifungal compounds. A member of this class of polyke-
tides, tetrafibricin from Streptomyces neyagawaensis
(Scheme 1), is a potent inhibitor of the fibrinogen receptor,
which suggests an even wider potential utility for such com-
pounds [8,9].
We have previously shown that in the biosynthesis of giant
macrocyclic antifungal polyketides (so-called marginolactones)
compounds bearing a terminal amino moiety are formed by spe-
cific final-stage deamidination of a precursor bearing a guani-
dino substituent at this position [10]. The aim of the present
study was to test whether the same "protective group" strategy
is operating in the biosynthesis of the giant linear mediomycins.
If true, then mediomycin A formation involves quite distinctive
late-stage processing: both an O-sulfonation step and a deamidi-
nation step. O-Sulfonation in particular is a rare and interesting
modification seen in diverse microbial natural products
(Scheme S1, Supporting Information File 1) including the non-
glycosylated teicoplanin-related antibacterial A47934 [11], the
engineered trisubstituted sulfoteicoplanin aglycone G [12], the
echinocandin-like FR901379 [13]; and the sulfated carbapenem
MM4550 [14]. A specific amidinohydrolase has been found
encoded in the respective biosynthetic gene clusters for the
marginolactone antibiotics primycin and desertomycin [10] but
not in the reported cluster for mediomycin in S. blastmyceticus
[8], so the enzyme hypothesised to be responsible for this step
in mediomycin biosynthesis has not been identified until now.
We present here the characterisation of the med biosynthetic
gene cluster, the successful identification of a specific
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Scheme 2: The biosynthetic gene clusters for mediomycin (med) from Streptomyces mediocidicus and clethramycin (cle) from S. malaysiensis
DSM4137. The numbers refer to the position of each orf in the genome sequence.
mediomycin amidinohydrolase encoded at a location on the
genome remote from the med cluster, and genetic and biochem-
ical evidence for the respective roles played by these sulfotrans-
ferase and amidinohydrolase enzymes in the production of
mediomycins.
Results and Discussion
We have previously [10] sequenced the biosynthetic gene
cluster for clethramycin from S. malaysiensis DSM4137 (cle);
and we have now also sequenced the cluster for mediomycins A
and B from S. mediocidicus (med), by whole-genome
sequencing of the strain. Clethramycin and desulfo-
clethramycin were not previously known to be produced by
S. malaysiensis DSM4137, but the identity of these metabolites
in cell extracts was readily confirmed by high-resolution mass
analysis (Figure S1, Supporting Information File 1). The prop-
erties of the genes and proteins in the med cluster and cle cluster
are summarised in Table S4 (Supporting Information File 1).
Both gene clusters encode a giant modular PKS housing 27
extension modules, distributed across nine PKS subunits
(Scheme 2). This is exactly the number of extension modules
predicted on the basis of the known structures of 1a–d. Detailed
comparison of our amino acid sequences for the Cle PKS [10]
and the Med PKS with the sequence recently reported for the
Med PKS of S. blastmyceticus [8] showed in each case a high
degree of amino acid sequence identity across the entire PKS
(≈96% identity) and essentially perfect conservation of se-
quence in each of the characteristic active site sequence motifs
for the ketosynthase (KS), acyltransferase (AT), ketoreductase
(KR), dehydratase (DH), and enoylreductase (ER) domains of
each of the 27 extension modules, including the newly-recog-
nised YGP motif of active DH domains [8] between the three
PKS multienzymes. The stereochemistry of 1a–d shown in
Scheme 1 is that predicted from the biosynthetic analysis; and is
in full agreement with the experimentally-determined relative
configuration of stereocentres in mediomycin [7,8]. The
flanking genes are also for the most part near-identical, includ-
ing a sulfotransferase (slf) gene that appears to mark one bound-
ary of the cluster. However, in the cle cluster there are addition-
al putative regulatory and export genes, as well as, remarkably,
a set of six genes interpolated into the cluster that are predicted
to govern lantibiotic biosynthesis (Scheme 2).
The key difference expected between the cle and the med clus-
ters was the presence of an essential amidinohydrolase gene,
encoding an enzyme that would act at a late stage in the path-
way to unmask the primary amino group of the mediomycins,
as we have previously described for the biosynthesis of amino-
marginolactone antibiotics [10]. However, careful scrutiny of
the open reading frames flanking the PKS in the med biosyn-
thetic gene cluster failed to reveal any whose product could be
plausibly construed to be an amidinohydrolase. The reported
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Figure 1: HPLC–UV–MS analysis of polyenes. A) LC–UV (360 nm) trace of mycelium methanol extract from DSM4137 wild type, showing the produc-
tion of clethramycin (1a) and desulfoclethramycin (1b) at m/z 1240.8 ([M + Na]+) and 1138.8 ([M + H]+) , respectively. B) LC–UV (360 nm) trace of
mycelium methanol extract from DSM4137 complemented with amidinohydrolase gene medi4948 from S. mediocidicus, showing clethramycin (1a)
and desulfoclethramycin (1b) are fully converted to the corresponding amino forms, mediomycin A (1c) and mediomycin B (1d) at m/z 1198.8
([M + Na]+) and 1096.8 ([M + H]+), respectively. C) LC–UV (360 nm) trace of mycelium methanol extract from S. mediocidicus, showing the
production of mediomycin A (1c) and mediomycin B (1d).
S. blastmyceticus med cluster also lacks the expected amidino-
hydrolase [8]. We therefore sought to locate the "missing"
amidinohydrolase by BLAST analysis [15] of our near-com-
plete genome sequence of S. mediocidicus using as a probe the
protein sequence of a putative amidinohydrolase (Orf32) from
the biosynthetic gene cluster of the linear polyene ECO-02301
(Scheme 1) [16]. The analysis returned two strong matches,
Medi4948 (80% identity, 93% similarity) and Medi2865 (82%
identity, 92% similarity), both provisionally annotated as
agmatinases (the numbers quoted refer to the position of the
respective orf in the genome sequence). The next best match
was a further agmatinase Medi0234 (41% identity, 57% simi-
larity). Each of these three genes was cloned and expressed in
Escherichia coli as an N-terminally histidine-tagged protein as
described in the Experimental section, and purified by chroma-
tography on a Ni-NTA column. The putative amidinohydro-
lases Medi2865 and Medi0234 were wholly inactive when incu-
bated with desulfoclethramycin (1b) purified from DSM4137
extracts, although Medi2865 did show metal-dependent amidi-
nohydrolase activity against 4-guanidinobutyrate to yield
4-aminobutanoate. In contrast, recombinant Medi4948 upon
brief incubation gave essentially complete conversion of puri-
fied 1b into mediomycin B (1d, see later). The gene encoding
this enzyme is located 670 kbp distant from the med gene
cluster on the S. mediocidicus chromosome (Scheme 2), a rare
but not unprecedented [17] example of an apparently essential
gene being located far from the relevant gene cluster. Because
the S. mediocidicus strain proved highly resistant to introduc-
tion of cloned DNA, we were unable to obtain formal proof that
this gene is essential for mediomycin biosynthesis by mutating
medi4948 and seeing accumulation of 1a and/or 1b. Instead, we
introduced the medi4948 gene, cloned in expression vector
pIB139 [18] into DSM4137. As shown in Figure 1B, in extracts
of the culture pellet of this recombinant the normal products of
this strain 1a and 1b were absent, and replaced by mediomycins
1c and 1d, fully consistent with the proposed function of the
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Figure 2: HPLC–UV–MS analysis of polyenes from DSM4137 wild type and mutants. A) LC–UV (360 nm) trace of mycelium methanol extract from
DSM4137 wild type, showing the production of clethramycin (1a) and desulfoclethramycin (1b). B) LC–UV (360 nm) trace of mycelium methanol
extract from the Δsmala2697 deletion mutant. In the mutant, production of 1a was completely abolished. C) LC–UV (360 nm) trace of mycelium meth-
anol extract from the Δsmala2697 deletion mutant complemented with smala2697 from DSM4137. D) LC–UV (360 nm) trace of mycelium methanol
extract from the Δsmala2697 deletion mutant complemented with the polyene cluster-associated slf gene (medi5536) from S. mediocidicus. Both
complementations restored the production of sulfonated polyene 1a.
amidinohydrolase encoded by gene medi4948. In contrast, when
an authentic amidinohydrolase from the Streptomyces olivaceus
Tü4018 strain producing the macrocyclic polyene deserto-
mycin [10] was similarly cloned and expressed in
S. malaysiensis DSM4137, it had no effect on the production of
1a and 1b (Figure S6, Supporting Information File 1), implying
that these amidinotransferases operating on linear and macro-
cyclic polyenes do not have overlapping substrate specificities.
Sequence alignment of amidinohydrolase Medi4948 with
authentic ureohydrolases in the Protein Data Bank (PDB)
(Figure S2, Supporting Information File 1) revealed that it
contains the sequence motifs xGGDH, DAHxD, and
SxDxDxxDPxxxP (where x = any amino acid), which are
conserved in this enzyme superfamily and are implicated in
cation binding and catalysis [19-22].
Our finding that amidinohydrolase encoded by the medi4948
gene acts on both desulfoclethramycin (1b) and clethramycin
(1a) in vivo raised the question of whether there is a preferred
or even obligatory order of events in the late-stage tailoring of
the mediomycins in S. mediocidicus. In order to resolve this
question we sought to characterise the putative sulfotransferase
encoded by the polyene-cluster associated slf gene in both
S. malaysiensis DSM4137 and S. mediocidicus (Table S4, Sup-
porting Information File 1). The polyene cluster-associated slf
gene in S. malaysiensis DSM4137 (smala2697) was specifi-
cally deleted in-frame as described in the Experimental section.
The resulting mutant strain, under conditions where the wild
type produces both 1a and 1b, only produced 1b (Figure 2B)
showing that the slf gene is uniquely responsible for the conver-
sion of desulfoclethramycin into clethramycin. Complementa-
tion of the mutant was carried out with either a wild type copy
of slf from DSM4137 (smala2697, or its counterpart from
S. mediocidicus (medi5536). In each case, co-production of 1a
was fully restored (Figure 2C and 2D).
These in vivo results together establish that Medi4948 is
capable of deprotection of both 1a and 1b and that the sulfo-
transferase SMALA_2697 (or Medi5536) is responsible for
converting 1b into 1a, as indicated in Scheme 3.
What remained unclear was whether the sulfotransferase is
capable of acting on both 1b and 1d, which would mean that
there are two independent routes to forming mediomycin A. We
Beilstein J. Org. Chem. 2017, 13, 2408–2415.
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Scheme 3: The parallel pathways for the biosynthesis of mediomycin A.
Figure 3: HPLC–UV–MS analysis of in vitro assays with amidinohydrolase Medi4948 and sulfotransferase Slf from S. malaysiensis DSM4137
(SMALA_2697). A) LC–UV (360 nm) trace of control assay, where purified 1b at m/z 1138.8 ([M + H]+) was incubated without enzyme. B) LC–UV
(360 nm) trace of 1b incubated with amidinohydrolase Medi4948, showing complete convertion of desulfoclethramycin (1b) to its amino form
mediomycin B (1d) at m/z 1096.8 ([M + H]+). C) LC–UV (360 nm) trace of 1b incubated with sulfotransferase SMALA_2697 and PAPS, showing com-
plete convertion of desulfoclethramycin (1b) to its sulfonated form clethramycin (1a) at m/z 1240.8 ([M + Na]+). D) LC–UV (360 nm) trace of 1b incu-
bated with amidinohydrolase Medi4948 to generate mediomycin B (1d) in situ, followed by addition of sulfotransferase SMALA_2697 and PAPS to
convert mediomycin B (1d) to mediomycin A (1c) at m/z 1198.8 ([M + Na]+).
first confirmed that when purified recombinant Slf from
DSM4137 (SMALA_2697) was incubated with 1b, in the pres-
ence of the cofactor 3′-phosphoadenosine-5′-phosphosulfate
(PAPS), 1a was formed (Figure 3C). Then, 1b was pre-incubat-
ed with amidinohydrolase Medi4948, to convert it fully into
mediomycin B 1d, as monitored by HPLC–MS (Figure 3B).
Beilstein J. Org. Chem. 2017, 13, 2408–2415.
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Then, Slf from DSM4137 (SMALA_2697) was added to the
reaction mixture together with PAPS. As shown in Figure 3D,
1d was efficiently converted into 1c under these conditions.
Therefore parallel pathways do exist (Scheme 3) for the forma-
tion of mediomycin A (1c) from desulfoclethramycin (1b),
which is the full-length initial product of the assembly-line PKS
in both clethramycin and mediomycin biosynthesis. The sulfo-
transferases from the cle and med clusters appear essentially
identical in their catalytic activity.
The co-location of the slf gene with the gigantic 27-extension
module PKS of clethramycin or mediomycin suggested that the
Slf protein sequence might be a useful probe to uncover further
examples of strains producing these or closely-related com-
pounds. BLAST analysis of public databases using the protein
sequence of the Slf of DSM4137 as a probe sequence uncov-
ered multiple candidate Slf sequences (see sequence alignment
in Figure S3, Supporting Information File 1) all of which bear
the conserved sequence motifs for binding of the sulfo-donor
PAPS. Some, but by no means all, of the genes for these Slf se-
quences are indeed co-located with giant PKS genes (these are
coloured green) in the phylogenetic tree of Slf sequences
presented in Figure S3 (Supporting Information File 1). This
analysis shows that slf genes associated with remarkable
biosynthetic gene clusters harbouring 27-module PKS genes are
distributed quite widely among Streptomyces strains. Because
the mediomycin amidinohydrolase gene is not located anywhere
near the med biosynthetic gene cluster, it is presently not
possible to distinguish with confidence, on sequence compari-
sons alone, between clethramycin and mediomycin clusters.
Conclusion
The accelerating speed and ever-decreasing cost of sequencing
of microbial genomes has spurred our interest in a genome-led
approach to the uncovering of novel enzymology in the biosyn-
thetic pathways to antibiotic natural products [23-26]. Here, we
have used in-house whole-genome sequencing to characterise
the closely-related gene clusters to the sulfated antifungal linear
polyenes clethramycin and mediomycin A. Further, it has
enabled a successful search for the key amidinohydrolase en-
zyme required for late-stage deprotection of clethramycins to
mediomycins, the gene for which is found 670 kbp distant from
the med gene cluster. We have also shown that the amidinohy-
drolase can act either before or after the specific sulfonation
step. The sequence of the sulfotransferase is a useful probe to
uncover related gene clusters in public sequence databases.
Sulfonation remains a rare and relatively poorly understood
modification in natural product biosynthesis [27-30]. As our
understanding of their specificity improves, sulfotransferases
have been deployed to increase the structural diversity of
several classes of natural products [31-33]. The slf genes of
polyene biosynthesis reported here represent an additional
starting point for such natural product diversification. Sulfona-
tion has been suggested as a novel approach to block the devel-
opment of antibiotic resistance [33,34] while the discovery of
the sulfated metabolite FR901379 was a critical breakthrough in
the successful clinical development of micafungin to combat
systemic fungal infections [12].
Supporting Information
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